Last updated: 16 June 2019 at 9:46pm EST

Russell D Hays Net Worth




The estimated Net Worth of Russell D Hays is at least $217 mil dollars as of 7 March 2014. Russell Hays owns over 15,000 units of Lemaitre Vascular Inc stock worth over $216,875 and over the last 17 years Russell sold LMAT stock worth over $0.

Russell Hays LMAT stock SEC Form 4 insiders trading

Russell has made over 2 trades of the Lemaitre Vascular Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Russell exercised 15,000 units of LMAT stock worth $94,950 on 7 March 2014.

The largest trade Russell's ever made was exercising 15,000 units of Lemaitre Vascular Inc stock on 7 March 2014 worth over $94,950. On average, Russell trades about 3,333 units every 24 days since 2008. As of 7 March 2014 Russell still owns at least 2,500 units of Lemaitre Vascular Inc stock.

You can see the complete history of Russell Hays stock trades at the bottom of the page.



What's Russell Hays's mailing address?

Russell's mailing address filed with the SEC is C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON, MA, 01803.

Insiders trading at Lemaitre Vascular Inc

Over the last 18 years, insiders at Lemaitre Vascular Inc have traded over $169,251,022 worth of Lemaitre Vascular Inc stock and bought 22,755 units worth $292,783 . The most active insiders traders include George W Le Maitre, Guido J Neels, eDavid B Roberts. On average, Lemaitre Vascular Inc executives and independent directors trade stock every 10 days with the average trade being worth of $1,488,890. The most recent stock trade was executed by David B Roberts on 13 August 2024, trading 3,063 units of LMAT stock currently worth $107,236.



What does Lemaitre Vascular Inc do?

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.



Complete history of Russell Hays stock trades at Lemaitre Vascular Inc

Acionista maioritário
Trans.
Transação
Preço total
Russell D Hays
Diretor
Exercício de opção $94,950
7 Mar 2014
Russell D Hays
Diretor
Exercício de opção $48,000
2 Aug 2013


Lemaitre Vascular Inc executives and stock owners

Lemaitre Vascular Inc executives and other stock owners filed with the SEC include: